RARE (Ultragenyx Corp) Quick Liquidity Indicator

Ultragenyx Pharmaceutical (RARE) - corporate logo

The current quick liquidity position of Ultragenyx Pharmaceutical (RARE) demonstrates the company's solvency, with the latest value recorded as 1.49. The firm adheres to ESG standards by optimizing drug logistics for environmental sustainability. The implementation of AI and robotics in bioanalysis is accelerating drug development. A high-tech R&D pipeline ensures the release of unique mRNA therapies to combat the rarest genetic pathologies.

Ultragenyx Pharmaceutical Inc. (RARE) Intermediate Coverage Ratio: for the period 07/04/2022 - 10/31/2026

Metric breakdowns and analytics for ultragenyx.com (RARE)

- market value and analyst target forecast:
Price Chart Ultragenyx Pharma|RARE - Price Target Chart
- business market valuation indicators:
Market Valuation Ultragenyx Pharma|RARE - Aggregate Business Value
- book capitalization indicators:
Net Assets per Single Share Ultragenyx|RARE - Accounting Value of Company|Market Capitalization to Book Value Ratio ultragenyx.com|RARE - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Capital Ultragenyx Pharmaceutical|RARE - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Ultragenyx|RARE - Company Cumulative Debt|Debt to Book Capitalization Ratio Ultragenyx Pharma|RARE - Company Long-Term Indebtedness|Company Current Liabilities Ultragenyx|Quick Liquidity Indicator ultragenyx.com
- earnings and market multiples details:
RARE - Company Profit
Comprehensive company analysis:Ultragenyx Pharmaceutical
Flagship merchandise of ultragenyx.com

The quick ratio measures a company's ability to settle short-term debts using its most liquid assets, intentionally excluding hard-to-sell inventories. By utilizing the quick ratio analysis on GURU.Markets, investors assess the financial cushion of Ultragenyx Pharmaceutical (RARE), which is critical for survival amid costly drug development and fierce competition with biotech behemoths for patent superiority.

Key competitors

Tempus (TEM) - Quick Liquidity|QGEN (Qiagen Corp) - Quick Liquidity|Quick Liquidity Indicator IONS|RGEN (repligen.com) - Intermediate Liquidity Ratio|Quick Liquidity Avidity Biosciences, Inc. (RNA)|CRSP (CRISPR Therapeutics Inc) - Intermediate Coverage Ratio|Quick Ratio WGS (Sema4)|Quick Ratio Beam Tx BEAM|Sarepta Therapeutics, Inc. - Quick Ratio|Critical Liquidity twistbioscience.com (TWST)|TXG: Quick Ratio|Immediate Liquidity Intellia Therapeutics Inc (NTLA)|Quick Liquidity Stoke|Immediate Liquidity Ratio BLFS (BioLife)|Quick Liquidity Indicator WVE (Wave Life Sciences)|MAZE - Immediate Liquidity|Sionna Therapeutics - Quick Liquidity Indicator|PRME: Immediate Liquidity Ratio|TSHA: Quick Liquidity Indicator|Intermediate Coverage Ratio QURE (uniQure Pharma)|MeiraGTx Holdings plc (MGTX) - Quick Liquidity|Critical Liquidity Ratio RGNX (regenxbio.com)|SLDB (Solid Biosciences) - Quick Ratio|OCGN: Intermediate Coverage Ratio|Quick Ratio PACB|Quick Ratio Benitec Corp (BNTC)|Quick Liquidity Design Therapeutics DSGN|Intermediate Coverage Ratio RCKT|FDMT - Quick Liquidity|Lexeo Therapeutics (LXEO) - Quick Liquidity Indicator|KRRO: Quick Ratio|Editas Corp (EDIT) - Quick Ratio|SLN (Silence Therapeutics) - Quick Ratio|Quick Liquidity Indicator ProQR Therapeutics NV (PRQR)|Quick Ratio CDXS|SGMO - Immediate Liquidity|Nautilus Bio - Quick Liquidity Indicator|Quick Ratio Metagenomi Therapeutics MGX|DTIL: Quick Liquidity Indicator|Generation Bio Co. - Intermediate Liquidity Ratio|BOLD: Quick Ratio|XCUR - Interim Coverage Ratio|IMNN (Imunon Inc) - Quick Ratio|Quick Liquidity Indicator RXi Pharmaceuticals (PHIO)|Quick Ratio MBIO|Quick Ratio transcodetherapeutics.com (RNAZ)|Quick Liquidity Bionano Genomics BNGO|Applied DNA Sciences Inc - Quick Liquidity|BLUE - Quick Liquidity|Intermediate Coverage Ratio IPA (ImmunoPrecise Antibodies)|OMGA: Quick Ratio|singulargenomics.com (OMIC) - Quick Ratio|Quick Liquidity Regulus Therapeutics Inc.|SYRS: Intermediate Coverage Ratio|Quick Ratio TBIO|TCON - Immediate Liquidity|Quick Ratio UBX (Unity Biotechnology)